[Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
Vakhrushev
Ia M
IaM
Belova
E V
EV
Efremova
L I
LI
D000293:Adolescent; D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001341:Autonomic Nervous System / Q000187:drug effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D012794:Sialic Acids / Q000032:analysis; D016896:Treatment Outcome
D000897:Anti-Ulcer Agents; D000928:Antidepressive Agents; D012794:Sialic Acids; D001569:Benzodiazepines; C012582:tofisopam